Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $38.0000 (-9.74%) ($35.2000 - $42.5000) on Tue. Oct. 7, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.75% (three month average) | RSI | 53 | Latest Price | $38.0000(-9.74%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) JNK(7%) PEJ(7%) VT(7%) XLF(7%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.375% in a week (0% probabilities). VIXM(-5%) TLT(-4%) SHY(-2%) GLD(-2%) UUP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.375% (StdDev 4.75%) | Hourly BBV | 0 () | Intraday Trend | -9.7% | | | |
|
Resistance Level | $40.36 | 5 Day Moving Average | $39.64(-4.14%) | 10 Day Moving Average | $39.49(-3.77%) | 20 Day Moving Average | $40.36(-5.85%) | To recent high | -13.8% | To recent low | 0.8% | Market Cap | $749m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |